Genetics of cancer Flashcards
What is the ‘two-hit’ hypothesis (Knudson)
Paticular reference to retinoblastoma - some occured early in infancy and some later.
Develop 1 mutation (somatic) then eventually a 2nd mutation= uncontrolled
If you already inherit one faulty copy but if a few cell divisions develop a 2nd mutation (hit) = triggers cancer
Is cancer inherited?
Cancer is not inherited. it is the predisposition/tendency that’s inherited
Genetic changes occurring in somatic cells. Accumulating errors in the genome= lack of control of growth of tissues.
What are proto-oncogenes.
Proto-oncogenes (acceleration)
Important in normal cell growth. when you have a mutation, there is a ‘gain of function’ and more activity of that gene. usually somatic mutations.
(stuck on accelerator)
Tumor supressor genes
normal function is to suppress inappropriate cell proliferation
loss of function of ‘breaks’
both alleles must be hit (the second by a somatic hit)
recessive at cellular level
examples: retinoblastoma, BRCA1
(break is not working)
Philadelphia Chromosome
Chronic myeloid leukaemia. fusion protein is created. Translocation of gene 9 and 22.
What is methylation of DNA?
If DNA is methylated it’s inactive.
hypomethylation: If you under methylate the chromatin there is relative instability = oncogene activation
if a region is hypermethylated - switch of tumour surpressor gene activity = contributes to onset of cancer.
Retinoblastoma
tumour in the back of eye
early on in infancy
child is blind (no red reflex= photographs)
screened by ophthalmologists
Peutz-Jeghers syndrome
haematomas lesions on the lips
risk of intussusception
39% risk of colon cancer
mutation in STK11 gene
Manchester scoring system
Number of cancers Weighted for age diagnosis Female breast cancer Male breast cancer Ovarian cancer Prostate cancer Pancreatic cancer
BRCA1 mutation carriers
early breast surveillants mammography and MRI
Risk reducing surgery
Hereditary colorectal cancer (CRC)
Lynch syndrome / Non polyposis colon cancer (HNPCC)
Familal adenomatous polyposis (FAP)
MYH associated polyposis (MAP)
Diffuse gastric cancer (e-cadherin)